Inhibition of PCSK9 affects serum lipoprotein functions in patients with familial hypercholesterolemia. (August 2022)

Record Type:: Journal Article
Title:: Inhibition of PCSK9 affects serum lipoprotein functions in patients with familial hypercholesterolemia. (August 2022)
Main Title:: Inhibition of PCSK9 affects serum lipoprotein functions in patients with familial hypercholesterolemia
Authors:: Palumbo, M.
Adorni, M.P.
Zimetti, F.
Pavanello, C.
Giammanco, A.
Cefalù, A.B.
Noto, D.
Piro, S.
Di Pino, A.
Averna, M.
Calabresi, L.
Bernini, F.
Purrello, F.
Scicali, R.
Abstract:
Is Part Of:: Atherosclerosis. Volume 355(2022)
Journal:: Atherosclerosis
Issue:: Volume 355(2022)
Issue Display:: Volume 355, Issue 2022 (2022)
Year:: 2022
Volume:: 355
Issue:: 2022
Issue Sort Value:: 2022-0355-2022-0000
Page Start:: 75
Page End:
Publication Date:: 2022-08
Subjects:: Arteriosclerosis -- Periodicals
Electronic journals
616.136
Journal URLs:: http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.atherosclerosis.2022.06.452 ↗
Languages:: English
ISSNs:: 0021-9150
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 23286.xml